JAMIE RUP: Open Payments
NPI 1205468543 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 26 payments from 15 companies in 2025. Trend: 2023 $306 · 2024 $522 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $125 |
| Lilly USA, LLC | 5 | $104 |
| Astellas Pharma US Inc | 2 | $44 |
| Exact Sciences Corporation | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| PFIZER INC. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: Wegovy, JARDIANCE, MOUNJARO, Ozempic, Veozah, FANAPT, Kerendia, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
